In prostate cancer, immunoprecipitation and signaling studies showed that CAV1 interacts with insulin- and IGF-1 receptors (IR/IGF-1R), and can stimulate IR kinase activities by also interacting with low-density lipoprotein receptor-related protein 6 (LRP6). This evidence concerns the gene LRP6 and Familial prostate cancer.